EVOLUTION OF INVESTIGATOR-INITIATED CLINICAL STUDIES IN A HEALTH RESEARCH INSTITUTE

被引：0
|
作者：
Llanos, L. [1 ]
机构：
[1] Fdn Jimenez Diaz, Hlth Res Inst, CEIC FJD, Madrid, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2016年 / 119卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CP80
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [31] Why do we need noncommercial, investigator-initiated clinical trials?
    Alan Tyndall
    Nature Clinical Practice Rheumatology, 2008, 4 : 354 - 355
  • [32] Trends in Investigator-Initiated Clinical Studies at a University Hospital after Enforcement of the 2018 Clinical Trials Act in Japan
    Sato, Yasutaka
    Sakaguchi, Satoshi
    Takechi, Kenshi
    Chuma, Masayuki
    Yagi, Kenta
    Kane, Chikako
    Goda, Mitsuhiro
    Hamano, Hirofumi
    Aoe, Yuki
    Nokihara, Hiroshi
    Kubo, Yoshiaki
    Hashimoto, Ichiro
    Yanagawa, Hiroaki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (03) : 374 - 377
  • [33] Innovative approaches to investigator-initiated, multicentre paediatric clinical trials in Canada
    Kelly, Lauren E.
    Richer, Lawrence
    Ali, Samina
    Plint, Amy C.
    Poonai, Naveen
    Freedman, Stephen B.
    Knisley, Lisa
    Shimmin, Carolyn
    Hickes, Serena
    t Jong, Geert W.
    Pechlivanoglou, Petros
    Offringa, Martin
    Lacaze, Thierry
    Klassen, Terry P.
    BMJ OPEN, 2019, 9 (06):
  • [34] Cost of insurance policies for investigator-initiated cancer clinical trials in Italy
    Perrone, F
    Marangolo, M
    Di Costanzo, F
    Colucci, G
    Repetto, L
    Merlano, M
    De Placido, S
    Torri, V
    Comella, G
    Labianca, R
    Parisi, V
    Gallo, C
    TUMORI JOURNAL, 2005, 91 (04): : 373 - 379
  • [35] Why do we need noncommercial, investigator-initiated clinical trials?
    Tyndall, Alan
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (07): : 354 - 355
  • [36] Investigator-Initiated Clinical Pharmacokinetic Studies in Resource-Limited Settings: Minimal Requirements and Practical Guidance
    Uittenboogaard, Aniek
    Mageto, Susan
    Mohamed, Sherif Kamal Eldin
    Pourroy, Bertrand
    Mwesige, Benjamin
    Chitedze, Agness Chisomo
    Kaspers, Gertjan
    Njuguna, Festus
    JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [37] Quality assurance for investigator-initiated trials.
    Allent, Karen O.
    El Shayeb, Mohamed
    Saleh, Mansoor N.
    Fiveash, John B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] The necessity of investigator-initiated trials in cardiothoracic surgery
    Velho, Tiago R.
    Guerra, Nuno
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2023, 64 (02)
  • [39] Investigator-initiated trials of targeted oncology agents: why independent research is at risk?
    Bergmann, L.
    Berns, B.
    Dalgleish, A. G.
    von Euler, M.
    Hecht, T. T.
    Lappin, G. L.
    Reed, N.
    Palmeri, S.
    Smyth, J.
    Embacher-Aichorn, S.
    Zwierzina, H.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1573 - 1578
  • [40] Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
    Yaegashi, Hiroko
    Hayashi, Yukikazu
    Takeda, Makoto
    Chiu, Shih-Wei
    Nakayama, Haruhiko
    Ito, Hiroyuki
    Takano, Atsushi
    Tsuboi, Masahiro
    Teramoto, Koji
    Suzuki, Hiroyuki
    Kato, Tatsuya
    Yasui, Hiroshi
    Nagamura, Fumitaka
    Daigo, Yataro
    Yamaguchi, Takuhiro
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (06) : 1031 - 1041
12345